Results: The level of INF-γ in Rif-Resistance vs Rif-sensitive PTB was 439.8 AE 52.029 pg/mL vs 336.68 AE 11.951 gp/mL and IL-17 level was 4.39 AE .986 pg/mL vs 4.0 AE .935 pg/mL. The level of IFN-γ was 81.3 AE 6.33 pg/mL and IL-17 was 2.3 AE ,32 pg/mL in HC. Both cytokines were not significantly different among all PTB patients (P >0.05) but significantly different from healthy control (P < 0.05). The level of IFN-γ in Rif-resistance and Rif-sensitive PTB to form severity of chest radiographs was not significantly different (P > 0.05). Neither with IL-17 level in Rifresistance and Rif-sensitive PTB (P > 0.05).
sitive PTB patients, although it were not significantly different. These two cytokines cannot be used to distinguish chest radiograph severity in Rifresistance and Rif-sensitive PTB patients. Hallym University Kangdong Sacred Heart Hospital, South Korea, and 2 Jeju National University Hospital, South Korea Background and Aims: Although it is necessary to culture Mycobacterium tuberculosis from tuberculous lymphadenitis (TBL) to enable clinicians to tailor the therapy, based on the drug-sensitivity test (DST), substantial numbers of TBL remain culture-negative. Limited data are available regarding the treatment outcomes and recurrence rates after standard short-course anti-tuberculosis treatment in patients with culturenegative TBL. The aim of this study was to compare treatment outcomes and recurrence rates between a tailored anti-tuberculosis regimen based on individual DST result and a standard anti-tuberculosis regimen due to unavailable DST because of culture-negative in TBL patients.
Methods:
We analysed the data of all patients with TBL from the TB registry database at five hospitals of Hallym Medical center, South Korea, during 2011-2015. The study population was divided into two groups according to regimen.
Results: Tailored and Standard anti-tuberculosis therapy were administered to respectively 44 and 163 patients with TBL. Drug resistance was detected in 3 (6.8 %) of patients with TBL, one case whom was multidrug-resistant. The treatment completion rate was not significantly different between the two groups (97.8 % vs 98.7 %). During a median 28-months follow-up, the recurrence rate was also similar in both groups (2.2 % vs 2.4 %).
Conclusion: Despite several limitations, these results support the hypothesis that immunocompetent patients with culture-negative TBL can be appropriately managed with a standard short-course anti-tuberculosis regimen, in this era of not increasing concerns about drug resistance. Background and Aims: Global data showed the high rates of Tuberculosis Diabetic Mellitus (TB-DM) incidence in the world, Asia as well as in Indonesia. Neutrophil-lymphocyte ratio (NLR) is a laboratory marker that can be used for systemic inflammation in TB-DM and also it is an available and cost-effective biomarker used in clinical practice that has been associated with recurrence and survival in various diseases, one of them TB-DM. It is necessary to cut off point NLR in TB-DM to know disease activity in Tuberculosis and Diabetic Mellitus Patients. The aim of our study is to investigate the value of neutrophil-to-lymphocyte ratio (NLR) as a possible marker to know disease activity in Tuberculosis and Diabetic Mellitus Patients.
Methods: This study is a retrospective cohort study with using secondary data between January 2016 and March 2018 taken with consecutive sampling in Cipto Mangunkusumo National Center General Hospital, Indonesia. Sampling was done by consecutive sampling with 181 patient.
This study was analysed with descriptive analysis and ROC curve. Result: Among the 181 patients in this study, 89 (49%) had TB-DM and 92 (51%) had TB non DM with complete neutrophil and lymphocyte data available. The area under curve ROC 0,726 with 95% CI got the cut of point NLR was 2.9. Patient with NLR > 2.9 (N = 100) and < 2.9 (N = 81).
Conclusion : In conclusion, NLR has attracted attention as a new inflammatory marker. The best cut-off value of NLR was 2.9 in predicting disease activity TBDM patients and this displayed a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy value (67, 66, 61.7, 71.7 and 66.8) . The patient with NLR < 2.9 has immunocompetent and > 2.9 has immunocompromise. Many factors affect NLR was associated with disease activity in TB-DM.
